Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mayo Clinic
Age
18–66
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults over the age of 18-66
At least a 12 month history of hemicrania continua (unremitting subtype) according to International Classification of Headache Disorders, 3rd Edition (ICHD-3)1
Previous or current complete response to indomethacin
Stable preventive treatment for at least 2 months and no anticipated need to adjust/add current headache prevention treatment
You may not be if
Nonresponse to a therapeutic dose of indomethacin for hemicrania continua when used for at least 1 week
Pregnant or lactating subjects
Use of barbiturate or opioid \>6 days per month; history of chronic migraine
History of previous trigeminal-autonomic cephalalgia
History within previous 2 months of interventional procedure for headache (occipital or other extracranial nerve block, sphenopalatine ganglion block, cervical facet block, facet rhizotomy)
History of cranial nerve/rhizolysis
Botulinumtoxin injection with previous 4 months
Parenteral infusion of or oral corticosteroid use for more than 3 days within 4 weeks prior to screening phase
Clareo Health | Erenumab For Treatment of Hemicrania Continua
